Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Regeneron, Navistar Rise Premarket; AMC Entertainment Falls

Published 10/05/2020, 07:53 AM
Updated 10/05/2020, 07:54 AM
© Reuters.

© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Monday, October 5th. Please refresh for updates.

  • Regeneron (NASDAQ:REGN) stock rose 5.3%, climbing after President Trump was given the company’s experimental Covid antibody treatment, suggesting that the drug was likely to be approved for general use in the future. The biotech was also upgraded to “overweight” from “neutral” by Cantor Fitzgerald.

  • Navistar (NYSE:NAV) stock rose 2.2% following reports that major shareholder Carl Icahn is willing to accept a bid of about $50 per share for the truck maker.
  • AMC Entertainment (NYSE:AMC) stock fell 6.9% after rival cinema chain, Cineworld, announced the closure of its more than 500 U.S. Regal theaters, as well as its theaters in the U.K.

  • Eidos Therapeutics (NASDAQ:EIDX) stock soared 31% after BridgeBio Pharma (NASDAQ:BBIO), up 0.1%, agreed to buy the biotech in a deal valuing Eidos at $2.8 billion.

  • AT&T (NYSE:T) stock fell 0.8% after KeyBanc Capital downgraded its investment stance on the telecoms giant to “underweight” from “sector weight”, citing declining average revenue per user numbers.

  • Square (NYSE:SQ) rose 2.3% after Susquehanna raised its price target on the credit-card payment processing company to $195 from $180.

  • MyoKardia (NASDAQ:MYOK) stock soared 58% after Bristol-Myers Squibb (NYSE:BMY), down 0.7%, announced plans to buy the heart drugs developer for about $13 billion, paying $225 per share in cash, a 61.2% premium on Friday closing price.

  • 3M (NYSE:MMM) stock rose 0.2% after saying it has launched an aggressive legal effort to prevent the sale of fraudulent personal protective equipment products during the coronavirus pandemic.

  • DraftKings (NASDAQ:DKNG) stock fell 4.9% after the sports and sports betting operator said it’s set to offer 32 million shares in a syndicated deal, half by the company and half by selling stockholders, with the money raised by the company to be used for general corporate purposes.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.